ArticleWorld journal of surgical oncology2025
Application of three-anatomical-plane dissection technique in the partial nephrectomy of renal cell carcinoma abutting the hilum gulf.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo describe the application of a three-anatomical-plane dissection (TAPD) technique for RCC-AHG and evaluate its feasibility and safety. DESIGN, SETTING, AND
participantsBetween June 2019 and October 2023, 42 patients undergoing PN using the TAPD technique at Ruijin Hospital were included. The data collected including patient demographic characteristics, oncological characteristics, perioperative and follow-up data on complications, renal function, recurrence and metastasis within 12 months after surgery. SURGICAL PROCEDURES: Patients underwent robotic or laparoscopic surgery by the transabdominal or retroperitoneal approach, depending on the tumor location. The three contact planes of the RCC-AHG tumor were anatomically dissected sequentially: the interface between the tumor and the perirenal fat (C1), the interface between the tumor and the renal hilum vessels (C2), and the interface between the tumor and the kidney parenchyma (C3). RESULTS AND LIMITATIONS: A total of 42 RCC-AHG patients were eventually enrolled. The median tumor diameter was 35.51 ± 13.99 cm; RENAL score: 9 (range: 8-11); no postoperative complications with Clavien-Dindo classification ≥ 2 (0.0%); no positive surgical margins (0.0%); the median differences of eGFR between the preoperative and 1 day, 3 months, 6 months and 12 months after surgery: -10.99 ± 15.49, -9.59(-18.02-0.75), -7.98(-17.41-1.53) and - 2.13(-9.94-2.76) mL/min/1.73 m
conclusionsTAPD-based PN for RCC-AHG is safe and feasible and does not hinder renal function significantly. This technique may become a new surgical strategy for the treatment of RCC-AHG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.